Dr. Rachel Lee Feldman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4901 Thompson Pkwy, Johnstown, CO 80534 Phone: 303-338-4545 |
Dr. Giovanna Milagros Garcia, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4901 Thompson Pkwy, Johnstown, CO 80534 Phone: 303-338-4545 |
Marc Anthony Masotti, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4401a Union St, Johnstown, CO 80534 Phone: 801-783-5011 Fax: 801-746-3734 |
Dr. Jinyi Ling, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4901 Thompson Pkwy, Johnstown, CO 80534 Phone: 303-338-4545 |
News Archive
Congenital rubella syndrome, a birth defect caused by the rubella virus (also known as German measles), has practically been eliminated in the U.S., according to a statement published in the April 2006 issue of Birth Defects Research Part A, the official journal of The Teratology Society.
The U.S. Food and Drug Administration today ordered manufacturers of certain types of pedicle screw systems, called dynamic stabilization systems, to conduct postmarket surveillance studies to collect clinical data on a number of potential safety issues, including fusion rates and frequency of additional surgeries.
Scientists from The University of Manchester - part of the Manchester Cancer Research Centre - used a simple protein test that could prove more useful in predicting survival chances for patients with head-and-neck cancer compared to existing methods.
Increased orthopaedic surgical procedures and an ageing baby boomer generation have been boosting the demand for bone grafts. Even as new applications and innovative products create exciting growth opportunities, the key challenge for bone graft substitutes suppliers is to produce material with clinical efficacy equivalent to, or surpassing, existing alternatives.
Cancer patients with blood clots - which occur in one of every 200 cancer patients and are the second most common cause of death among cancer patients - gain no benefit from the insertion of an inferior vena cava filter (IVCF) to the anticoagulant medication fondaparinux (Arixtra), according to research presented today at the 14th World Conference on Lung Cancer, hosted by the International Association for the Study of Lung Cancer.
› Verified 5 days ago